Equillium (EQ) EBITDA (2018 - 2026)

Equillium (EQ) has 9 years of EBITDA data on file, last reported at -$5.3 million in Q1 2026.

• Quarterly EBITDA rose 39.06% year-over-year to -$5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.4 million (down 41.94% YoY) and the FY2025 annual result came in at -$22.8 million, down 207.24% from the prior year.
• EBITDA retreated to -$5.3 million in Q1 2026 per EQ's latest filing, from -$3.7 million in the prior quarter.
• Across five years, EBITDA topped out at $2.7 million in Q4 2022 and bottomed at -$37.7 million in Q1 2022.
• The 5-year median for EBITDA is -$3.7 million (2023), against an average of -$6.5 million.
• The widest annual swing landed in 2022, when EBITDA surged 124.84%; it then plunged 2155.74% in 2025.
• Tracing EQ's EBITDA over 5 years: stood at $2.7 million in 2022, then tumbled by 200.15% to -$2.7 million in 2023, then sank by 88.35% to -$5.0 million in 2024, then advanced by 26.51% to -$3.7 million in 2025, then plunged by 44.05% to -$5.3 million in 2026.
• Per Business Quant, the three latest EQ EBITDA figures stand at -$5.3 million (Q1 2026), -$3.7 million (Q4 2025), and -$4.3 million (Q3 2025).

Peer Comparison